HPC Biosciences Financials

BSE: 535217

₹25.68

₹-0.52 (-1.98%)

As on 29-Jul-2024IST

Market cap

₹410 Cr

Revenue (TTM)

₹2 Cr

P/E Ratio

--

P/B Ratio

12.5

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Operating Revenue	2.29	1.20	1.60	1.94	2.26	1.87
Total Income	2.37	1.30	1.69	2.08	2.44	2.01
Total Expenditure	0.67	0.33	0.39	1.00	0.88	0.12
EBITDA	1.62	0.87	1.21	0.94	1.37	1.75
Depreciation	0.51	0.61	0.72	0.84	0.99	1.38
EBIT	1.11	0.26	0.49	0.10	0.38	0.37
Interest	0.00	0.00	0.00	0.01	0.00	0.01
Other Income	0.09	0.10	0.09	0.14	0.19	0.14
Exceptional Items	--	--	--	--	--	--
Profit before Tax	1.19	0.36	0.58	0.23	0.57	0.50
Provision for Tax	0.02	0.02	0.02	0.03	0.06	0.04
Profit after Tax	1.17	0.34	0.55	0.20	0.51	0.46

Liabilities (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Shareholder's Funds	32.85	31.68	31.34	30.79	30.59	30.09
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	0.28	0.46	0.56	0.47	0.40	0.10
Total Liabilities	33.13	32.14	31.90	31.26	31.00	30.19

Assets (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Non-Current Assets	7.06	7.57	8.18	8.90	9.74	10.73
Current Assets	26.07	24.57	23.72	22.34	21.17	19.25
Total Assets	33.13	32.14	31.90	31.26	31.00	30.19
Total Debt*	--	--	--	--	--	--
Net Current Assets	25.79	24.11	23.16	21.87	20.77	19.15
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Cash From Operating Activities	1.36	0.82	1.17	0.08	1.09	-0.18
Cash Flow from Investing Activities	0.06	-0.79	-0.96	-0.10	-1.87	0.17
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	1.42	0.03	0.21	-0.02	-0.77	-0.02

Financials Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Adjusted EPS (₹)	0.07	0.02	0.03	0.01	0.03	0.03
Cash EPS (₹)	0.11	0.06	0.08	0.07	0.09	0.12
Adjusted Book Value (₹)	2.06	1.99	1.96	1.93	1.91	1.87
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	0.09	0.05	0.07	0.01	0.07	-0.01
Free Cash Flow per Share (₹)	0.09	0.06	0.08	0.01	0.07	-0.01

Profitability Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
ROCE (%)	3.69	1.14	1.86	0.78	1.88	1.73
ROE (%)	3.62	1.07	1.78	0.64	1.68	1.56
ROA (%)	3.58	1.05	1.75	0.63	1.66	1.54
EBIT Margin (%)	48.41	21.45	30.58	5.25	16.96	19.84
Net Margin (%)	49.32	25.86	32.80	9.45	20.77	22.91
Cash Profit Margin (%)	73.59	78.87	79.37	53.41	66.39	98.64

Growth Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Revenue Growth (%)	90.55	-25.03	-17.73	-13.87	20.91	-39.64
EBIT Growth (%)	330.09	-47.42	378.90	-73.32	3.34	-36.95
Net Profit Growth (%)	247.42	-39.26	181.45	-61.22	10.27	-34.69
EPS Growth (%)	247.39	-39.23	182.31	-61.32	10.03	-34.62
Book Value Growth (%)	3.69	1.09	1.86	0.86	2.10	1.98

Valuation Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Price / Earnings	--	--	--	3,286.72	1,526.73	1,448.81
Price / Book Value	--	--	--	21.03	25.40	22.33
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	9.19	16.17	12.12	598.21	496.53	351.75
Close Price (₹)	--	--	--	40.55	48.55	41.80
High Price (₹)	--	--	--	47.60	50.50	66.00
Low Price (₹)	--	--	--	40.55	41.00	28.90
Market Cap (₹ Cr)	--	--	--	647.18	774.86	667.13

Solvency Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	92.99	53.95	42.49	47.41	52.59	192.77
Quick Ratio	91.04	52.19	40.91	45.46	49.55	180.16
Interest Coverage	2,897.08	1,956.75	369.11	28.83	150.94	63.08

Operating Efficiency Ratios	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11
Debtors to sales (%)	249.39	452.06	330.84	265.34	171.73	174.71
Asset Turnover	0.07	0.04	0.05	0.06	0.07	0.06
Receivable days	888.10	1,630.41	1,192.36	848.13	577.12	512.37
Inventory Days	107.96	256.43	205.59	201.10	200.57	188.39
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	996.06	1,886.83	1,397.95	1,049.23	--	--